" /> Blog and News - Edinburgh Innovations

News and blog

US drug firm licenses breakthrough Edinburgh cancer discovery

The University of Edinburgh and US biopharmaceutical company Nuvectis Pharma, Inc., have signed a multi-million-dollar licensing deal to turn a...
Agreement targets disease-resistant gene-edited pigs

Agreement targets disease-resistant gene-edited pigs

The University of Edinburgh’s Roslin Institute and animal genetics company Genus PLC have signed an agreement to produce pigs that are resistant to a respiratory disease affecting livestock worldwide. Researchers and the company hope the licensing...

read more
Investing in innovation, from bench to bedside

Investing in innovation, from bench to bedside

At the forefront of research to develop gene therapy treatment for Rett syndrome is the University of Edinburgh’s Dr. Stuart Cobb, his team and their partnership with Neurogene. Neurogene began working with Dr. Stuart Cobb shortly after its...

read more
Bench to bedside: with industry all the way

Bench to bedside: with industry all the way

Collaborations with pharmaceutical companies not only facilitate the transition of a scientific discovery from bench to bedside, but as the University of Edinburgh’s Dr Veronique Miron discovered, can also contribute to career development as a...

read more
Dr Andrea Taylor named Head of Major Projects

Dr Andrea Taylor named Head of Major Projects

Edinburgh Innovations has named Dr Andrea Taylor as its new Head of Major Projects. Dr Taylor will lead Edinburgh Innovations’ Major Projects team, which focuses on developing the University’s long-term strategic relationships with commercial...

read more

Contact us to find out how we can help